BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20942110)

  • 21. Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis and predictor of an erosive disease.
    Orbach H; Gilburd B; Brickman CM; Gerli R; Shoenfeld Y
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):892-3. PubMed ID: 12455175
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis.
    van Halm VP; Slot MC; Nurmohamed MT; Tervaert JW; Dijkmans BA; Voskuyl AE
    Ann Rheum Dis; 2006 May; 65(5):590-4. PubMed ID: 16249230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab.
    Lequerré T; Jouen F; Brazier M; Clayssens S; Klemmer N; Ménard JF; Mejjad O; Daragon A; Tron F; Le Loët X; Vittecoq O
    Rheumatology (Oxford); 2007 Mar; 46(3):446-53. PubMed ID: 16899502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance of citrullinated collagen type II and its antibodies in rheumatoid arthritis].
    Tian X; Bi LQ; Li ZG
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(33):2334-8. PubMed ID: 17156630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Novel autoantibodies for the diagnosis of rheumatoid arthritis].
    Steiner G; Smolen JS
    Z Rheumatol; 2002 Dec; 61(6):667-73. PubMed ID: 12491130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
    Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP
    J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
    Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A
    Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis].
    Yalaoui S
    Arch Inst Pasteur Tunis; 2006; 83(1-4):13-7. PubMed ID: 19388592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-Purkinje cell antibody (anti-Yo/type 1 antibody)].
    Tanaka K
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():526-9. PubMed ID: 20942120
    [No Abstract]   [Full Text] [Related]  

  • 32. Autoantibodies against human calpastatin in rheumatoid arthritis: epitope mapping and analysis of patient sera.
    Lackner KJ; Schlosser U; Lang B; Schmitz G
    Br J Rheumatol; 1998 Nov; 37(11):1164-71. PubMed ID: 9851263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel autoantibody markers for early and seronegative rheumatoid arthritis.
    Somers K; Geusens P; Elewaut D; De Keyser F; Rummens JL; Coenen M; Blom M; Stinissen P; Somers V
    J Autoimmun; 2011 Feb; 36(1):33-46. PubMed ID: 21071175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: a highly effective test for the diagnosis of rheumatoid arthritis.
    Vincent C; Nogueira L; Sebbag M; Chapuy-Regaud S; Arnaud M; Letourneur O; Rolland D; Fournié B; Cantagrel A; Jolivet M; Serre G
    Arthritis Rheum; 2002 Aug; 46(8):2051-8. PubMed ID: 12209508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunologic tests: Anti-mitochondrial antibody].
    Miyakawa H
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():536-40. PubMed ID: 16111324
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anti-PL-7, anti-PL-12, and other anti-aminoacyl tRNA synthetase antibodies].
    Hirakata M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():555-9. PubMed ID: 20942128
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome.
    Kovács L; Marczinovits I; György A; Tóth GK; Dorgai L; Pál J; Molnár J; Pokorny G
    Rheumatology (Oxford); 2005 Aug; 44(8):1021-5. PubMed ID: 15888503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis.
    Richards PJ; Nowell MA; Horiuchi S; McLoughlin RM; Fielding CA; Grau S; Yamamoto N; Ehrmann M; Rose-John S; Williams AS; Topley N; Jones SA
    Arthritis Rheum; 2006 May; 54(5):1662-72. PubMed ID: 16646038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.
    Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J
    N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.
    Ménard HA
    J Rheumatol; 2009 Apr; 36(4):663-4. PubMed ID: 19342718
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.